Sector: Health Care
Director information for HALOZYME THERAPEUTICS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Barbara Duncan | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business"] | [] | 2026 | ||
| Bernadette Connaughton | ["Medicine and Science", "Pharma Business Leadership and Operations"] | [] | 2026 | ||
| Cortney Caudill | Senior Vice President, Chief Operating Officer | [] | [] | 2026 | |
| Helen I. Torley | President and Chief Executive Officer | [] | [] | 2026 | |
| Helen I. Torley | M.B. Ch.B., M.R.C.P. | ["Medicine and Science", "Pharma Business Leadership and Operations", "International Business", "Human Capital Management", "Finance and Capital Markets", "M&A", "Risk Management"] | [] | 2026 | |
| James Lang | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business"] | [] | 2026 | ||
| Jeffrey W. Henderson | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business", "Human Capital Management", "Finance and Capital Markets", "M&A", "Risk Management"] | [] | 2026 | ||
| Mahesh Krishnan, M.D. | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business", "Human Capital Management", "Finance and Capital Markets"] | [] | 2026 | ||
| Matthew L. Posard | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business", "Human Capital Management"] | [] | 2026 | ||
| Michael J. LaBarre | Former Senior Vice President, Chief Technical Officer | [] | [] | 2026 | |
| Moni Miyashita | ["Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business"] | [] | 2026 |
